Table Of Content

INDEX TO POSTGRADUATE VOLUME 92 MEDICINE JULY-DECEMBER 1992 SUBJECTS ACCIDENT PREVENTION AIRWAY OBSTRUCTION BITES AND STINGS operative factors affecting out- e OSHA’S new regulations on e Anaphylaxis, management, e Animal bites, current manage- come. 92(5):265* bloodborne pathogens. (ED) preventive measures. 92(5):277* ment guidelines. 92(1):134* ¢ Coronary artery disease risk 92(1):17 e Asthma, diagnostic approach. e Anopheles mosquito, malaria, factors in persons with type Il di- ACNE 92(3):80* prophylaxis for world travelers. abetes, relationship to glucose ¢ Retinoid therapy, benefits and e Asthma, new approach to 92(3):161* metabolism. 92(2):105* risks, guidelines for treatment. management. 92(6):177* BLOOD e Hypertension in elderly, treat- 92(6):193 ¢ In aspiration pneumonia. 92(1): e Autologous transfusion, an- ment recommendations. 92(1): e Vulgaris, topical and systemic 168 swers to commonly asked ques- 237* therapies. 92(5):181* ALCOHOLISM tions. 92(3):253* ¢ Hypertension in post-myocar- ACQUIRED IMMUNODEFICIENCY ¢ Cause of sideroblastic anemia, BREAST DISEASES dial infarction patient, pharma- SYNDROME (AIDS) hematologic evaluation. (CR) ¢ Cancer, legal issues in man- cotherapy for long-term out- ¢ HIV infection in athletes, risks 92(7):147 agement. 92(5):137* come. 92(3):173* in sports setting, guidelines for ALLERGY ¢ Common breast lesions, evalu- * Hypertension, interrelation- sports physicians. 92(7):73* e Anaphylactic reaction, man- ation and management. 92(5):95* ships to exercise and antihyper- ¢ Rheumatic syndromes in HIV- agement of medical emergency, ¢ Mammographic imaging of tensive drug therapy. 92(6):139* infected patients. 92(4):99* preventive measures. 92(5):277* breast, overview of capabilities ¢ Implantable cardioverter-defib- © Seropositive but asymptomatic ¢ Role in asthma. 92(3):83* and limitations. 92(5):117* rillators for prevention of sudden patients, evaluation and manage- ANAPHYLAXIS ¢ Mammography. (PN) 92(5):353 cardiac death, current recom- ment by primary care physician. ¢ Management and prevention mendations. 92(1):301* 92(5):155* of medical emergency. 92(5):277* CANCER: See Neoplasms * Ischemic heart disease, preop- ADOLESCENT MEDICINE: See ANEMIA CARDIOVASCULAR D erative risk assessment. 92(5): Pediatrics ¢ Of chronic disease, clues to e Antiatherosclerotic effects of AGING differentiate from iron deficiency. calcium channel blockers for hy- ¢ Myocardial infarction, acute, e Age-related skin changes, 92(4):123* pertension. 92(2):265* assessing damage and predict- benefits and risks of retinoid ¢ Sideroblastic, alcohol-induced, © Atrial fibrillation, anticoagulant ing prognosis with nuclear myo- therapy, guidelines for treatment. hematologic evaluation. (CR) therapy, recommendations from cardial perfusion imaging. 92(7): 92(6):191* 92(7):147 recent studies. 92(3):119* ¢ Common thyroid disorders, ANTIBIOTICS: See Drugs, antibi- ¢ Beneficial cardiac effects of ¢ Myocardial infarction, acute, accurate diagnosis and rational otic hormone replacement therapy. updated protocol for thrombolyt- management. 92(3):225* ARTHRITIS: See Rheumatic dis- 92(4):146 ic therapy. 92(1):209* e Fever of unknown origin in el- eases ¢ Cardiac complications follow- ¢ Myocardial infarction, assess- derly, steps to diagnosis. 92(5): ASTHMA ing surgery, role of primary care ing long-term prognosis. 92(8): 197° e Avoiding triggers. (PN) 92(4): physician in prevention. 92(3): 107* ¢ Hypertension, treatment rec- 175 89* ¢ Myocardial infarction, using ommendations. 92(1):237* © Diagnostic approach. 92(3):80* ¢ Cardiac complications of sub- echocardiography in evaluation. e Postoperative acute confu- * Metered-dose inhalers. (PN) stance abuse. 92(3):205 92(7):97* sional state in elderly, role of pri- 92(3):274 ¢ Cardiac enzyme levels in con- ¢ Myocardial infarctior, various mary care physician in preven- ¢ Metered-dose inhalers and firming acute myocardial infarc- therapies to prevent reinfarction tion. 92(3):196 spacer devices. 92(3):95* tion. 92(7):85* 92(8):84* e Risk factor for acute confu- ¢ Occupational, mechanisms ¢ Cardiac imaging after acute e Post-myocardial infarction pa- sional state. 92(8):142 and causes, diagnosis, and treat- myocardial infarction to identify tient with hypertension, comple- ¢ Risk of bladder cancer in el- ment. 92(3):109* patients at continued risk. mentary use of beta blockers and derly men. 92(1):105 e Reevaluation of management 92(8):93* calcium channel blockers for ¢ Risk of tetanus, diagnosis and strategies, new approach in ¢ Cardiac irregularities from secoridary prevention. 92(3):173* treatment. 92(7):59* 1990s. 92(6):177* magnesium deficiency. 92(5):218 ¢ Postoperative myocardial in- ¢ Thrombolytic therapy for acute ¢ Wheezing and dyspnea result- ¢ Cardiac rehabilitation, level 1. farction, management. 92(5):2771 myocardial infarction in elderly. ing from vocal cord dysfunction, (PN) 92(7):179 ¢ Proarrhythmic complications 92(1):210 not asthma. (CR) 92(6):153 ¢ Cardiac rehabilitation, level 2. from quinidine. 92(4):133 AIDS: See Acquired immunodefi- (PN) 92(8):261 e Rehabilitation following heart ciency syndrome (AIDS) BEHAVIOR DISORDERS e Cardiovascular risk factors, attack. (PN) 92(7):179; (PN) 92(8): e Accompanying Tourette’s syn- psychophysiologic responses to 261 drome. 92(5):306 stress and clinical conse- e Rheumatic fever, resurgence in ¢ Acute confusional state, clini- quences. 92(5):237* United States, diagnosis and *Major clinical discussion cal presentation, evaluation, and ¢ Cerebral infarctions, diagnostic treatment. 92(3):133* CR, Case Report management. 92(8):141* studies and therapeutic regimens e Risk in obese patients. 92(1): ED, Editorial BIOPSY that help avoid stroke in middle- 155 MEM, Memories Worth Sharing e Renal, in evaluation of adults aged and older patients. 92(2): ¢ Sudden cardiac death during PH, Physician-at-Large with primary nephrotic syndrome. 221 exercise, identifying those at risk. PN, Patient Notes 92(2):213 * Coronary artery disease, peri- 92(2):195* continued VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED e Vascular complications of sub- relationship to glucose metab- ment for women with acute uri- DRUGS, CALCIUM CHANNEL stance abuse. 92(3):207 olism. 92(2):105* nary tract infection. 92(6):159* BLOCKER CATHETERIZATION e Type Il (non-insulin-depen- ¢ For Crohn’s disease, results of ¢ Antiatherosclerotic effects. © Indwelling urinary catheters, dent), physician’s role in non- drug trials. 92(8):173 92(2):265* management recommendations. pharmacologic treatment and pa- e For infected animal bites. © Following myocardial infarction 92(1):127° tient education. 92(6):129* 92(1):136 to prevent reinfarction. 92(8):87 CHOLESTEROL DIAGNOSTIC TECHNIQUES e Macrolide, newer agents— ¢ For post-myocardial infarction e Effect of insulin on low-density ¢ Barium enema, role in detect- azithromycin and clarithromycin. patients with hypertension. 92(3): and high-density lipoproteins. ing colorectal disease, radiolo- 92(1):269* 175 92(2):106 gist’s perspective. 92(3):245* © Prophylaxis in cases of animal DRUGS, CONTRACEPTIVE COLD © Cardiac enzyme levels in con- bites. 92(1):136 ¢ Oral, benefits and risks. 92(7): © Hypothermia, diagnosis, treat- firming acute myocardial infarc- e Sulfasalazine in management 155” ment, and prognosis. 92(8):47* tion. 92(7):85* of Crohn’s disease, results of e Oral, role in management of COLONIC DISEASES: See Gas- e Cardiac imaging after acute drug trials. 92(8):168 endometriosis. 92(1):292 trointestinal diseases myocardial infarction to identify DRUGS, ANTICOAGULANT DRUGS, CORTICOSTEROID CONNECTIVE TISSUE DISEASE patients at continued risk. 92(8): e For atrial fibrillation, recom- e For asthma. 92(6):186 © Cause of fever in elderly. 92(5): 93* mendations based on results of ¢ In treating Crohn’s disease, re- 198 © Cost-effective screening for recent studies. 92(3):119* sults of drug trials. 92(8):170 CONTRAST MEDIA ovarian cancer. 92(8):63* ¢ To prevent reinfarction after DRUGS, DIURETIC e Radiocontrast-induced ne- ¢ Echocardiography, capabilities myocardial infarction. 92(8):88 ¢ For managing ascites in pa- phropathy, risk factors and pre- in evaluation cf myocardial in- DRUGS, ANTIDEPRESSANT tients with cirrhosis. 92(8):155 ventive measures. 92(8):215* farction. 92(7):97* e Use in physically ill patient DRUGS, HORMONE ¢ Objective testing for asthma. treated for depression. 92(3):149 ¢ Postmenopausal replacement DEATH/DYING 92(3):112 DRUGS, ANTIHISTAMINES therapy, risks, screening recom- ¢ Sudden, during exercise, his- e Preoperative, patients with ¢ Oral, first- and second-genera- mendations. 92(4):145* tory and causes, identifying ischemic heart disease. 92(5):257 tion, for pruritus. 92(7):43 DRUGS, IMMUNOSUPPRESSIVE those at risk. 92(2):195* e Serologic diagnosis of viral DRUGS, ANTIHYPERTENSIVE ¢ For Crohn's disease, results of DELIVERY OF HEALTHCARE hepatitis. 92(4):55* e Maximizing benefits of exer- drug trials. 92(8):170 ¢ Comparison of 11 healthcare DIARRHEA cise in patients receiving antihy- DRUGS, NONSTEROIDAL ANTI- plans. (ED) 92(2):21 e “Halloween,” side effect of sor- pertensive drug therapy. 92(6): INFLAMMATORY (NSAID) ¢ Comparisons of Bush and bitol-containing candy. (CR) 139° ¢ Cromolyn sodium for asthma. Clinton healthcare plans. (ED) 92(5):63 DRUGS, ANTIMALARIAL 92(6):185 92(5):15 e In Crohn’s disease, therapeutic ¢ Traits, benefits, and side ef- DRUGS, RETINOID © Letter to President-elect Clin- options. 92(8):168 fects. 92(3):165 e For acne and age-related skin ton. (ED) 92(8):21 DIET: See Nutrition DRUGS, ANTIMICROBIAL changes, benefits and risks, ¢ National health insurance, DRUG ABUSE e In management of community- guidelines for treatment. 92(6): Ralph Nader’s viewpoint. (ED) ¢ Medical complications, over- acquired pneumonia. 92(8):207 191 92(6):15 view. 92(3):205* DRUGS, ANTIPSYCHOTIC DRUGS, SALICYLATE ¢ President Bush’s healthcare DRUG INTERACTIONS e For delirium and acute psy- e Aspirin therapy for atrial fibril- plan for the nation—and an ¢ Systemic, with oral contracep- chosis. 92(5):320, 326, 328 lation, recent study results. 92(3): overview of his health status. tives. 92(7):162 DI , AN TIVIRAL 120 (ED) 92(4):13 © With sulfonylureas. 92(2):74 ¢ Interferon, for treatment of DRUGS, SIDE EFFECTS DEPRESSION DRUG THERAPY chronic hepatitis B and C. 92(4): ¢ Antidepressant therapy, risk- ¢ In physically ill patients, diag- e Drug trials on treatment of 75* benefit ratio in treating de- nosis, use of antidepressants, Crohn’s disease. 92(8):168* DRUGS, BETA AGONIST pressed, physically ill patients. tips on safe treatment. 92(3):147* e For asthma, new approach for e Metered-dose inhalers and 92(3):153 DIABETES 1990s. 92(6):177* spacer devices in management ¢ From quinidine. 92(4):132 ¢ Exercise—benefits, risks, pre- ¢ Thrombolytic therapy for acute of asthma, teaching correct use, ¢ From retinoid therapy of acne. cautions. 92(1):183* myocardial infarction, updated patient problems and solutions. 92(6):195 © Foot care. (PN) 92(2):289 protocol. 92(1):209* 92(3):95* DRUGS, SULFONYLUREA * Health risk of obesity. 92(1): © Zidovudine therapy for asymp- DRUGS, BETA BLOCKER ¢ Combined with insulin to treat 154 tomatic HIV-infected patients, ¢ Following myocardial! infarction type II diabetes. 92(2):89* ¢ Magnesium deficiency, causes when to start. 92(5):161 to prevent reinfarction. 92(8):87* e For non-insulin-dependent and effects. 92(5):217* DRUGS, ANGIOTENSIN-CONVERT- ¢ For post-myocardial infarction (type II) diabetes, when and when ¢ Non-insulin-dependent (type ING ENZYME INHIBITOR patients with hypertension. not to use. 92(2):69* ll), combining insulin and sulfo- ¢ To prevent reinfarction after 92(3):175 DRUGS, THROMBOLYTIC nylurea. 92(2):89* myocardial infarction. 92(8):87 DRUGS, BRONCHODILATOR ¢ Protocol for use in acute myo- ¢ Non-insulin-dependent (type DRUGS, AN HMIC ¢ Betas agonists for asthma. cardial infarction. 92(1):209* ll), rational use of sulfonylureas. © Quinidine, safety and effective- 92(6):183 DYSPHAGIA 92(2):69° ness. 92(4):131* e Theophylline preparations for ¢ Pinpointing cause with radio- © Type Il, lipid metabolism and DRUGS, ANTIBIOTIC asthma. 92(6):185 graphic, endoscopic, and mano- e Agents and course of treat- metric studies. 92(7):129* continued on page 233 VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED ECHOCARDIOGRAPHY ¢ Role in treating post-polio syn- ¢ Testicular cancer, screening IMMUNOLOGIC DISEASES e In evaluation of myocardial in- drome. 92(1):253 and education, role of primary ¢ Effects of substance abuse. farction. 92(7):97* EYE DISORDERS care physician. 92(1):93* 92(3):212 ¢ Two-dimensional, to identify ¢ Ophthalmic manifestations of e Testicular self-examination. © Impaired cell-mediated immu- patients at continued risk after Graves’ disease. 92(8):117 PN) 92(1):335 nity, factor in listerial meningitis. acute myocardial infarction. GERIATRICS: See Aging (CR) 92(8):191 92(8):95 FEVER GOVERNMENT AGENCIES ¢ Rheumatic syndromes in HIV- ELDERLY: See Aging « Rheumatic, resurgence in Unit- e OSHA’S new regulations on infected patients. 92(4):99" ELECTROCARDIOGRAPHY ed States, diagnosis and treat- bloodborne pathogens. (ED) INFECTION e In assessing risk factors and ment. 92(3):133* 92(1):17 — of fever in elderly. 92(5): long-term prognosis after myo- e Unknown origin in elderly, ¢ OSHA's response to informa- 197° cardial infarction. 92(8):107* steps to = 92(5):197* tion requests. (ED) 92(7):15 © Cause of pruritus. 92(7):36 ELECTROPHYSIOLOGIC STUDY FOOT DISORDERS GYNECOLOGY: See Obstetrics/ ¢ Community-acquired pneumo- ¢ Implantable cardioverter-defib- e In diabetics. (PN) 92(2):289 Gynecology nia, diagnosis and treatment. rillators for prevention of sudden FOREIGN BODIES 92(8):197* cardiac death, current recom- ¢ In gastrointestinal tract, guide- HEART DISEASE: See Cardiovas- © Complication of long-term uri- mendations. 92(1):301* lines for removal. 92(5):46* cular diseases nary catheterization, treatment EMERGENCY MEDICINE HEMATOLOGIC DISEASES recommendations. 92(1):129 e Anaphylaxis, management, GASTROINTESTINAL DISEASES ¢ Immune thrombocytopenic ¢ Human immunodeficiency preventive measures. 92(5):277 e Ascites in patients with cirrho- purpura, acute and chronic, clini- virus, evaluation and manage- ¢ Carbon monoxide poisoning, sis, treatment options. 92(8):155* cal features, laboratory findings, ment of seropositive but asymp- diagnosis and treatment. 92(4): e Barium enema in detection of and treatment options. 92(6):112 tomatic patient. 92(5):155* 86* colorectal diseases, radiologist’s © lron deficiency and anemia of ¢ Human immunodeficiency ¢ Hypothermia, recognizing sub- perspective. 92(3):245* chronic disease, diagnostic clues virus, in athietes, risks in sports tle signs and symptoms, treat- * Colon cancer, dietary effects. for differentiation. 92(4):123* setting, guidelines for sports ment and prognosis. 92(8):47* (PN) 92(6):221 * Sideroblastic anemia, alcohol- physicians. 92(7):73* ¢ Poisoning and overdose, cur- © Colonic div2rticula, overview of induced, hematologic evaluation. ¢ Listerial meningitis, sources of rent options for gastrointestinal therapeutic approaches. 92(6): (CR) 92(7):147 infection, coexisting conditions, decontamination and appropriate 97* HEMORRHOIDS and — tonatemaaeaa agents. (CR) applications. 92(2):116* ¢ Colorectal polyps, differentiat- © Office evaluation and manage- 92(8):191 ENDOCRINE DISORDERS ing benign from malignant, ment. 92(2):141 ¢ Malaria, or ye for world ¢ Addisonian crisis following screening and treatment, follow- HEPATITIS travelers. 92(3):16 surgery, role of primary care up and prevention. 92(6):53* e B and C, chronic, current drug ° a vaaieas. of bone and physician in prevention. 92(3):194 * Complications of substance treatment. 92(4):75* joint. 92(4):99 ¢ Cause of pruritus, evaluation abuse. 92(3):211 ¢ Viral, preexposure and postex- ¢ Perirectal and perianal ab- and treatment. 92(7):34 * Crohn’s disease, therapeutic posure prophylaxis. 92(4):43* scesses, office evaluation and ¢ Diabetes: See Diabetes options available, results of drug e Viral, tests for serologic diag- management. 92(2):144 ¢ Graves’ disease, treatment op- trials. 92(8):168* nosis. 92(4):55* ¢ Respiratory tract in children, tions. 92(8):117* e Dysphagia, pinpointing cause HEREDITARY DISEASES what helps and what doesn’t? e Thyroid disorders in elderly, with radiographic, endoscopic, ¢ Tourette’s syndrome, recogni- 92(2):235* accurate diagnosis and rational and manometric studies. 92(7): tion and management, promising e Rheumatic fever, resurgence in management. 92(3):225* 129° new drug therapies. 92(5):299* United States, diagnosis and ENVIRONMENTAL ¢ Foreign bodies in Gl tract, HORMONES treatment. 92(3):133* e Lead poisoning in children, guidelines for removal. 92(5):46* e Estrogen and progestin, bene- ¢ Risk with animal bites, current ramifications, screening and pre- e Gas and diarrhea caused by fits and risks. 92(7):155 management guidelines including vention. 92(5):69* sorbitol ingestion. (CR) 92(5):63 e Estrogen replacement therapy, antibiotic prophylaxis. 92(1):134* EQUIPMENT ¢ Gastrointestinal decontamina- postmenopausal protection. ¢ Tetanus, threat to elderly, diag- ¢ Metered-dose inhalers and tion after poisoning or overdose, 92(4):145* nosis and treatment, prevention spacer devices in asthma man- current options. 92(2):116* HYPERTENSION: See Cardiovas- with immunization. 92(7):59* agement, teaching correct use. e Inflammatory bowel disease, cular diseases e Urinary tract, acute, in women, 92(3):95* outpatient management. 92(6): HYPOTHERMIA changing ideas on treatment. EXERCISE e Diagnosis, treatment, and 92(6):159* e For patients with diabetes GENETIC DISORDERS: See He- prognosis. 92(8):47* INSOMNIA —benefits, risks, precautions. reditary diseases ¢ Situational, "as for treat- 92(1):183* GENITAL DISEASES IMMUNIZATION ment. 92(2):1 ¢ Interrelationships among exer- e Acute urinary tract infection in ¢ Current recommendations on INSULIN cise, hypertension, and antihy- women, changing ideas on treat- viral hepatitis. 92(4):43 e Used with sulfonylurea to treat pertensive drug therapy. 92(6): ment. 92(6):159* ¢ Tetanus status review in cases type Il diabetes. 92(2):89* 139* ¢ Female, endometriosis, diag- of animal bites. 92(1):144 INSURANCE, HEALTH ¢ Role in controlling non-insulin- nostic clues, treatment options. ¢ To prevent tetanus. 92(7):67 ¢ Comparison of 11 healthcare dependent diabetes. 92(6):129 92(1):283* plans. (ED) 92(2):21 continued VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED e Ralph Nader's pian for national MAMMOGRAPHY e Caused by tetanus, particularly OTORHINOLARYNGOLOGIC DiIS- health insurance. (ED) 92(6):15 ¢ Overview of capabilities and in elderly, diagnosis and treat- EASES e Reform in United States, com- limitations. 92(5):117* ment. 92(7):59* e Snoring, causes, complica- parisons of Bush and Clinton e Patient information. (PN) 92(5) ¢ Complications of substance tions, evaluation and manage- healthcare proposals. (ED) 92(5) 353 abuse. 92(3):207 ment. 92(3):217°* 15 MEDICAL PRACTICE e In listerial meningitis, sources e¢ Vocal cord dysfunction mim- INTESTINAL DISEASES: See Gas- ¢ How OSHA responds to com- of infection, coexisting condi- icking bronchial asthma. (CR) trointestinal diseases plaints about physicians’ office tions, and therapeutic agents 92(6):153 IRON practice methods. (ED) 92(3):29 (CR) 92(8):191 OXYGEN © Deficiency, differentiating from e OSHA’S new regulations on * Post-polio syndrome, possible ¢ Therapy for carbon monoxide anemia of chronic disease. 92(4) bloodborne pathogens. (ED) causes, current treatment poisoning. 92(4):93 123° 92(1):17 92(1):249* e Patient satisfaction, strategies © Stroke: See Stroke PATIENT EDUCATION KIDNEY DISEASES for avoiding formal complaints © Tourette’s syndrome, recogni- © Avoiding asthma triggers. (PN) e Cause of pruritus. 92(7):34 92(5):169 tion and management, promising 92(4):175 e Nephropathy, radiocontrast- MENINGITIS new drug therapies. 92(5):299* ¢ Breast self-examination. 92(5) induced, risk factors and preven- e Listerial, sources of infection, NUTRITION 95 tive measures. 92(8):215* coexisting conditions, and thera- e Diet and colon cancer. (PN) ¢ Cardiac rehabilitation, level 1 ¢ Nephrotic syndrome in adults, peutic agents. (CR) 92(8):191 92(6):221 (PN) 92(7):179 diagnosis and management MENSTRUATION DISORDERS e Eating behavior in obesity. ¢ Cardiac rehabilitation, level 2. 92(2):209* e¢ Amenorrhea and chronic 92(1):154 (PN) 92(8):261 ¢ Renal insufficiency, role in re- anovulation, finding and address- © Hypervitaminosis A. 92(6):199 © Counseling asymptomatic HIV- fractory ascites in patients with ing underlying cause. 92(2):255°* e Iron deficiency, cause of pruri- positive patients. 92(5):159 cirrhosis. 92(8):155 MUSCULOSKELETAL DISORDERS tus. 92(7):36 ¢ Diet and colon cancer. (PN) ¢ Muscle rigidity and spasm re- © Low-fiber diet and diverticular 92(6):221 LABORATORY INVESTIGATION sulting from tetanus, evaluation disease. 92(6):97 e Foot care for diabetics. (PN) e Cardiac enzyme levels in con- and treatment. 92(7):59 * Magnesium deficiency and di- 92(2):289 firming acute myocardial infarc- ¢ Myositis in HIV-infected pa- abetes, causes and effects. 92(5): ¢ Informed consent in manage- tion. 92(7):85* tients. 92(4):104 217° ment of breast disease, legal is- e In diagnosis of Graves’ dis- © Post-polio syndrome, possible ¢ Nutritional concerns in inflam- sues. 92(5):144 ease. 92(8):120 causes, current treatment. 92(1): matory bowel disease. 92(6):71 © Mammography. (PN) 92(5):353 * Serologic diagnosis of viral 249" ¢ Sorbitol in sugar-free foods, e Metered-dose inhalers. (PN) hepatitis. 92(4):55* side effects of gas and diarrhea. 92(3):274 ¢ Serum creatinine level in diag- NEOPLASMS (CR) 92(5):63 ¢ Role of physician in teaching nosis of radiocontrast-induced © Bladder cancer, identification, ¢ Weight loss and nutritional and offering support to control nephropathy. 92(8):222 staging, and treatment. 92(1): counseling in control of non- non-insulin-dependent diabetes. e Tests for detecting pathogen 105° insulin-dependent diabetes. 92(6):129* causing community-acquired ¢ Breast cancer, legal issues in 92(6):130 e Teaching correct use of me- pneumonia. 92(8):203 management. 92(5):137* tered-dose inhalers and spacer ¢ Thyroid function tests in elder- ¢ Breast cancer, mammographic OBESITY devices for asthma management. ly. 92(3):225 features. 92(5):118 e Medical implications. 92(1): 92(3):95* LIVER DISEASES ¢ Breast lesions, evaluation and 151° e Testicular self-examination. © Cirrhosis accompanied by as- management. 92(5):95* OBSTETRICS/GYNECOLOGY (PN) 92(1):335 cites, treatment options. 92(8): ¢ Colorectal polyps, screening e Amenorrhea and chronic PEDIATRICS and treatment, follow-up and anovulation, finding and address- e Acne vulgaris, topical and sys- ¢ Hepatitis B and C, chronic, prevention. 92(6):53* ing underlying cause. 92(2):255* temic therapies. 92(5):181* current drug treatment. 92(4):75* e Lymphoma, cause of fever in e Endometriosis, diagnostic e “Halloween diarrhea,” side ef- ¢ Viral hepatitis, preexposure elderly. 92(5):200 clues, treatment options. 92(1): fect of sorbitol-containing candy. and postexposure prophylaxis. ¢ Malignant, risk in obese pa- (CR) 92(5):63 92(4):43° tients. 92(1):156 * Oral contraceptives, benefits ¢ Immune thrombocytopenic ¢ Viral hepatitis, tests for sero- © Ovarian cancer, cost-effective and risks. 92(7):155* purpura, acute and chronic, clini- logic diagnosis. 92(4):55* screening methods. 92(8):63* e Ovarian cancer, cost-effective cal features, laboratory findings, ¢ Prostate cancer, update on screening methods. 92(8):63* and treatment options. 92(6):112* MAGNESIUM recognition and management. ¢ Postmenopausal hormone re- e Lead poisoning in children, © Deficiency in diabetics, causes 92(1):67* placement therapy. 92(4):145* ramifications, screening and pre- and effects. 92(5):217* ¢ Testicular cancer, screening e Reproductive complications of vention. 92(5):69* MALPRACTICE and education, role of primary substance abuse, effect on preg- e Respiratory infections, what ¢ Legal issues surrounding care physicians. 92(1):93 nancy. 92(3):213 helps and what doesn’t? 92(2): breast cancer care, recommen- NEUROLOGIC MANIFESTATIONS OCCUPATIONAL DISEASES 235* dations for decreasing liability e Acute confusional state, clini- e Asthma, mechanisms and ¢ Tetanus immunization. 92(7):67 risks. 92(5):137* cal presentation, evaluation, and causes, diagnosis, and treat- PHARYNGEAL Di management. 92(8):141* ment. 92(3):109* ¢ Pharyngitis and incidence of rheumatic fever in United States, VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE diagnosis and treatment. 92(3): ¢ Delirium and acute psychosis, RESPIRATORY DISEASES ¢ Testicular self-examination. 133* diagnosis and management. e Aspiration pneumonia, three (PN) 92(1):335 PHYSICAL EXAMINATION 92(5):319* distinct syndromes, recognition SKIN DISEASES ¢ Focused, in asymptomatic ¢ Depression in physically ill pa- and management, possibility of e Acne and age-related skin adults. 92(2):171* tients, diagnosis, use of antide- prevention. 92(1):165* changes, benefits and risks of PHYSICIAN-PATIENT RELATIONS pressants, tips on safe treatment. ¢ Asthma, diagnostic approach. retinoid therapy and guidelines e Assessing patient satisfaction, 92(3):147* 92(3):80* for treatment. 92(6):191* strategies for avoiding formal ¢ Obsessive-compulsive disor- e Asthma, management with ¢ Acne vulgaris, topical and sys- complaints. 92(5):169 der in patients with Tourette’s metered-dose inhalers and spac- ternic therapies. 92(5):181* PHYSICIANS syndrome. 92(5):306 er devices, teaching proper tech- e Pruritus, cutaneous and sys- * Sports, risks of HIV transmis- e Situational insomnia, guide- nique. 92(3):95* temic causes, treatment. 92(7): sion from infected athletes. 92(7): lines for treatment. 92(2):157* e Asthma, reevaluation of man- 34* 74 e Stress, psychophysiologic re- agement strategies. 92(6):177* SLEEP DISORDERS PNEUMONIA sponses and clinical conse- ¢ Avoiding triggers of asthma. ¢ Situational insomnia, guide- ¢ Aspiration, recognition and quences. 92(5):237* (PN) 92(4):175 lines for treatment. 92(2):157* management, possibility of pre- PUBLIC HEALTH * Carbon monoxide poisoning, e Snoring, causes, complica- vention. 92(1):165* ¢ Lead poisoning in children, so- diagnosis and treatment. 92(4): tions, evaluation and manage- ¢ Community-acquired, diagno- cietal ramifications, screening ment. 92(3):217* sis and treatment. 92(8):197* and prevention. 92(5):69* ¢ Infections in children, what SPORTS MEDICINE POISONING e Resurgence of rheumatic fever helps and what doesn’t? 92(2): © HIV infection in athletes, risks ¢ Carbon monoxide, diagnosis in United States. 92(3):133* in sports setting, guidelines for and treatment. 92(4):86* PULMONARY DISEASES: See ¢ Metered-dose inhalers. (PN) sports physicians. 92(7):73* ¢ Current options for gastroin- Respiratory diseases 92(3):274 STRESS testinal decontamination and ap- ¢ Occupational asthma, mecha- e Effect on heart, mechanisms, propriate applications. 92(2):116* RABIES nisms and causes, diagnosis and measurement, and management. © Lead, in children, ramifications, e Animal bites, current manage- treatment. 92(3):109* 92(5):237* screening and prevention. 92(5): ment guidelines including poten- e Pneumonia, community-ac- STROKE tial for rabies. 92(1):140 quired, diagnosis and treatment. e Avoiding, diagnostic studies POLYPS RADIOGRAPHY 92(8):197* and therapeutic regimens in mid- ¢ Colorectal, differentiating be- ¢ Chest, indications for use in ¢ Postoperative complications, dle-aged and older patients. nign and malignant, screening evaluating patients for pneumo- role of primary care physician in 92(2):221 and treatment, follow-up and nia. 92(8):202 prevention. 92(3):192 SUBSTANCE ABUSE: See Drug prevention. 92(6):53* RADIOLOGIC DIAGNOSIS ¢ Pulmonary complications of abuse PREGNANCY: See Obstetrics/Gy- e Barium enema in detecting substance abuse. 92(3):208 SURGERY necology colorectal disease, radiologist’s ¢ Respiratory symptoms result- ¢ For diverticular complications. PREVENTIVE MEDICINE perspective. 92(3):245* ing from vocal cord dysfunction. 92(6):101 ¢ Focused physical examination ¢ Cardiac imaging after acute (CR) 92(6):153 e Liver transplantation for refrac- in asymptomatic adults. 92(2): myocardial infarction to identify RHEUMATIC DISEASES tory ascites in patients with cir- 171* patients at -continued risk. e In HIV-infected patients. rhosis. 92(8):163 * Foot care in diabetics. (PN) 92(8):93* 92(4):99* © Management of endometriosis. 92(2):289 ¢ Mammographic imaging of 92(1):291 e Measures to prevent malaria breast, overview of capabilities SAFETY: See Accident prevention ¢ Noncardiac, in patients with for world travelers. 92(3):162 and limitations. 92(5):117* SCREENING ischemic heart disease, preoper- e Physician efforts to prevent ¢ Mammography. (PN) 92(5): 353 e Asymptomatic men for pros- ative risk assessment. 92(5):237* lead poisoning in ;oung children. ¢ Nuclear myocardial perfusion tate cancer. 92(1):71 e Perioperative factors affecting 92(5):71 imaging in acute myocardial in- 2 Athletes for risk of sudden car- outcome for patients with coro- ¢ Pneumonia prophylaxis in HIV- farction. 92(7):109* diac death. 92(2):205 nary artery disease, management infected patients. 92(5):162 RECTAL DISEASES ¢ Breast self-examination. 92(5): of postoperative myocardial in- e Preventing tetanus with immu- ¢ Colorectal polyps, screening 95 farction. 92(5):265* nization, prophylaxis after injury. and treatment, follow-up and ¢ For bladder cancer. 92(1):109 ¢ Preventing postoperative med- 92(7):67 prevention. 92(6):53* ¢ For colorectal cancer. 92(6):58 ical complications, role of prima- e Preventive strategies for viral ¢ Common anorectal problems, ¢ For lead exposure in children, ry care physician. 92(3):189* hepatitis, recommendations for office management. 92(2):141* CDC standards. 92(5):69 ¢ Vascular shunts for refractory preexposure and postexposure e Foreign bodies in rectum, e For ovarian cancer, cost-effec- ascites. 92(8):163 prophylaxis. 92(4):43* guidelines for removal. 92(5):56 tive methods. 92(8):63* PROSTATIC DISEASES e Role of barium enema in de- e For testicular cancer, role of THERAPEUTICS e Cancer, update on recognition tection, radiologist’s perspective. primary care physician in educa- e Environmental manipulation in and management. 92(1):67* 92(3):245* tion. 92(1):94 managing patients with delirium PSYCHIATRIC/PSYCHCSOCIAL REHABILITATION * Mammographic imaging of and acute psychosis. 92(5):319, DISORDERS © Cardiac, level 1. (PN) 92(7):179 breast, overview of capabilities 327 ¢ Acute confusional state, clini- © Cardiac, level 2. (PN) 92(8):261 and limitations. 92(5):117* e Interferon, for treatment of cal presentation, evaluation, and RENAL DISEASES: See Kidney ¢ Mammography. (PN) 92(5):353 chronic hepatitis B and C. 92(4): management. 92(8):141* diseases 75* continued VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED ¢ Oxygen therapy for carbon TRAVEL MEDICINE diagnosis and management. * Hepatitis, tests for serologic monoxide poisoning. 92(4):93 ¢ Malaria, prophylaxis for world 92(2):209* diagnosis. 92(4):55* ° Paracentesis in management travelers. 92(3):161* e Prostate cancer, update on ¢ Human immunodeficiency of ascites refractory to treatment TUMORS: See Neoplasms recognition and management. virus infection in athletes, risks in with diuretics. 92(8):161 92(1):67* sports setting, guidelines for THYROID DISEASES URINARY TRACT DISORDERS ¢ Testicular cancer, screening sports physicians. 92(7):73* ¢ Graves’ disease, treatment op- e Acute infection in women, and education, role of primary e Poliovirus, possible causes tions. 92(8):117* changing thoughts on treatment. care physician. 92(1):93* and current treatment of post- ¢ In elderly, accurate diagnosis 92(6):159* polio syndrome. 92(1):249* and rational management. 92(3): UROLOGIC DISEASES VACCINATION: See Immunization ¢ Rabies, potential in animal © Bladder cancer, identification, VASCULAR DISEASES: See Car- bites, management steps. THYROID FUNCTION TESTS staging, and treatment. 92(1): diovascular diseases 92(1):140 © In elderly. 92(3):225 105* VIRAL DISEASES VITAMINS TRAUMA e Indwelling urinary catheters, ¢ Hepatitis B and C, chronic, © Hypervitaminosis A. 92(6):199 e Animal bites, current manage- management recommendations. current drug treatment. 92(4):75* ment guidelines. 92(1):134* 92(1):127* * Hepatitis, preexposure and WOUNDS/INJURIES: See Trauma ¢ Carbon monoxide poisoning, ¢ Nephrotic syndrome in adults, postexposure prophylaxis. 92(4): diagnosis and treatment. 92(4):86* 43° AUTHORS ADLER CH tients are vulnerable? (CR) BERNSTEIN JA lems in independent and institu- See Dodick D 92(8):191 Occupational asthma: ‘My job tionalied patients. 92(1):127 AMIN NM ASTON JW Jr is making me sick!’ 92(3):109 BREITENBACH RA Prophylaxis for malaria: Helping Post-polio syndrome: An BIALER PA ‘Halloween diarrhea’: An unex- world travelers come home emerging threat to polio sur- See Westreich L pected trick of sorb. >I-contain- healthy. 92(3):161 vivors. 92(1):249 BLAKE GH ing candy. (CR) 92(5):63 ANDERSON CR AYOUB EM Control of type I! diabetes: BUFFA SD Animal bites: Guidelines to cur- Resurgence of rheumatic fever Reaping the rewards of exercise See Khawaja IT rent management. 92(1):134 in the United States: The and weight loss. 92(6):129 BURKE K ANDERSON EG changing picture of a preventable BLAND KI In sickness and in health. Eating humble pie. (MEM) iliness. 92(3):133 Evaluation of common breast (MEM) 92(5):81 92(8):75 masses. 92(5):95 BUSSE w Not the burying kind. (MEM) BEAN LC BODE FR Asthma in the 1990s: A new ap- 92(1):265 Cardiac imaging after acute See Mehra MR proach to therapy. 92(6):177 The shot felt ’round the world. myocardial infarction: |dentifi- BODEN WE BUTT F (MEM) 92(3):239 cation of patients at continued The post-myocardial infarction See Tenner S Wings of mercy. (MEM) 92(7): risk. 92(8):93 patient with hypertension: BUTT JH 117 BELL DSH Long-term outcome. 92(3):173 Outpatient management of in- APGAR BS Exercise for patients with dia- BOHANNON NJV flammatory bowel disease: Endometriosis: Diagnostic clues betes: Benefits, risks, precau- Lipid metabolism in type I! dia- Let’s keep it as simple as possi- and new treatment options. tions. 92(1):183 betes. 92(2):105 ble. 92(6):69 92(1):283 INETT HJ BRANDSTETTER RD APPLEGATE WB How to keep your practice in See Khawaja IT CAROME MA The hypertensive patient: Not the pink. (PH) 92(3):49 BRECHTELSBAUER DA Nephrotic syndrome in adults: just a number. 92(1):237 BERLAND 6B Care with an indwelling urinary A diagnostic and management ASHINSKY D Fever of unknown origin in the catheter: Tips for avoiding prob- challenge. 92(2):209 Listerial meningitis: Which pa- elderly: A sequential approach to continued diagnosis. 92(5):197 VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED CARR BR ELFRINK RJ Dear President Clinton. (ED) KUMAR S See Marshburn PB Colonic diverticula: When com- 92(8):21 Serologic diagnosis of viral CARUSO DR plications require surgery and Follow the rules: But tell us if hepatitis. 92(4):55 Intervention in Graves’ disease: when they don’t. 92(6):97 the feds target you unfairly! (ED) KUMASAKA BH Choosing among imperfect but ELIOT RS 92(1):17 Acne vulgaris: Topical and sys- effective treatment options. Stress and the heart: Mecha- The good and the bad about 11 temic therapies. 92(5):181 92(8):117 nisms, measurement, and man- healthcare plans. (ED) 92(2):21 CLARK R agement. 92(5):237 Hats and beds: Ralph Nader LANGE WR Breast imaging: A practical look ELNICKI DM thinks ‘it’s already working.’ (ED) Medical complications of sub- at its capabilities and its limita- Preventing postoperative medi- 92(6):15 stance abuse. 92(3):205 tions. 92(5):117 cal complications: How primary OSHA breaks a rule. (ED) LEUNG AKC CLARKSTON WK care physicians can help. 92(7):15 The ABZzzzs of snoring. Gastrointestinal foreign bodies: 92(3):189 Who was the phi phantom accuser 92(3):217 When to remove them, when to of 15 doctors? (ED) 92(3):29 LICHTENHAN JB watch and wait. 92(5):46 FARNES SW Tetanus: A threat to elderly pa- COELHO-BORGES S Retinoid therapy for aging skin HARRIS CR tients. 92(7):59 See Rogers Al and acne. 92(6):191 Gastrointestinal decontamina- LOVE N CORAPI MJ FILE TM Jr tion: Which method is best? Breast cancer: Improving your Coronary artery disease in sur- Community-acquired pneumo- 92(2):116 acumen in diagnosis. 92(5):85 gical patients: Perioperative nia: The changing picture. HAVLICHEK DH Mammography. (PN) 92(5):353 management. 92(5):265 92(8):197 See Stein GE See also Bland KI; Clark R; De- Coronary artery disease in sur- FOGOROS RN HIMBER P war MA gical patients: Preoperative How useful are implantable The wrong side of the bed. (PH) LYNCH JJ evaluation. 92(5):251 cardioverter defibrillators? 92(6):37 See Mamby SA CORREN J 92(1):301 HOUSTON MC Vocal cord dysfunction mim- FRANCIS T Exercise and hypertension: McHALE MS icking bronchial asthma. (CR) Common thyroid disorders in Maximizing the benefits in pa- See Vogt HB 92(6):153 the elderly. 92(3):225 tients receiving drug therapy. MACKNIN ML FRANK SH 92(6):139 Respiratory infections in chil- DAVIDSON MB The focused physical examina- dren: What helps and what Rational use of sulfonylureas. tion: Should checkups be tailor- JEWELL ME doesn’t? 92(2):235 92(2):69 made? 92(2):171 Asymptomatic HIV infection: A McRAE MA DELLA RATTA RK FREEDMAN SN primary care disease. 92(5):155 See Galle PC See Corapi MJ The role of barium enema in JOHNSON RJ MAMBY SA DePAOLIS M detecting colorectal disease: HIV infection in athletes: What Echocardiography: Using its Aggravation by mail. (PH) A radiologist’s perspective. are the risks? Who can com- many capabilities to evaluate 92(2):41 92(3):245 pie? 92(7):73 myocardial infarction. 92(7):97 The Big Bird doctor kit. (PH) Sudden death during exercise: MARSHALL JB 92(7):23 GALLE PC A cruel turn of events. 92(2):195 Diet and colon cancer. (PN) Doctors and other shoppers. Amenorrhea and chronic 92(6):221 (PH) 92(5):35 anovulation: Finding and ad- KAHN JK Polyps in the colon: Answers to Presents of mind. (PH) 92(8):27 dressing the underlying cause. Anticoagulant therapy for atrial key questions. 92(6):53 Soap suds. (PH) 92(4):19 92(2):255 fibrillation: Recommendations MARSHBURN PB Testing, one... two... (PH GILLIN JC from major studies. 92(3):119 Hormone replacement therapy: 92(1):31 Relief from situational insom- KELLERMAN RD Protection against the conse- DEWAR MA nia: Pharmacologic and other See Lichtenhan JB quences of menopause. 92(4): Legal issues in managing options. 92(2):157 KELSO TM 145 breast disease. 92(5):137 GLECKMAN RA See Self TH MATTIONI TA DINDZANS VJ See Berland B KEMP ED Long-term prognosis after myo- Viral hepatitis: Preexposure and GOLBUS J Prostate cancer: Finding and cardial infarction: Who is at risk postexposure prophylaxis. Rheumatic disease and AIDS: managing it. 92(1):67 for sudden death? 92(8):107 92(4):43 An interesting but mysterious re- KHAWAJA IT MAZZAFERRI EL DODICK D lationship. 92(4):99 Aspiration pneumonia: A threat See Caruso DR Tourette’s syndrome: Current GONZALEZ P when deglutition is compro- MEHRA MR approaches to recognition and See Tenner S mised. 92(1):165 Radiocontrast-induced ne- management. 92(5):299 GRIFFIN GC KINGSTON R phropathy: Prevention is better Avoiding things that trigger See Harris CR than cure. 92(8):215 EDMEADS J asthma. (PN) 92(4):175 KIRCHNER JT MIEDEMA BW How to avert impending stroke. Bush & his healthcare Acute and chronic immune See Elfrink RJ 92(2):221 plan—healthy! Some media re- thrombocytopenic purpura: MOHLER ER Jr ELDER NC ports—not! (ED) 92(4):13 Disorders that differ in more than lron deficiency and anemia of Acute urinary tract infection in Bush vs Clinton on artichokes, duration. 92(6):112 chronic disease: Clues to differ- women: What kind of antibiotic tomatoes, and healthcare. (ED) entiating these conditions. therapy is optimal? 92(6):159 92(5):15 92(4):123 continued VOL. 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED MOORE J Jr RUZICH RS SMITH LK VARON J See Carome MA Cardiac enzymes: How to use Medical treatment after myo- Hypothermia: Saving patients MOORE P serial determinations to confirm cardial infarction: Results of from the big chill. 92(8):47 See Frank SH acute myocardial infarction. studies using various methods. See also Sadovnikoff N 92(7):85 92(8}:84 VOGT HB NEMEC L SOWERS JR Testicular cancer: Role of pri- See Clark R SADOVNIKOFF N Antiatherosclerotic effects of mary care physicians in screen- NEWMAN KB Carbon monoxide poisoning: calcium channel blockers. ing and education. 92(1):93 See Corren J An occult epidemic. 92(4):86 92(2):265 See also Varon J STAHL TJ WARTOFSKY L ODLAND PB SALERNO DM Office management of com- See Francis T See Kumasaka BH Quinidine: Is it a good drug or a mon anorectal problems. WASSERSUG JD bad drug? 92(4):131 92(2):141 Giving thank: s. (MEM) 92(2):135 PETERSEN RC SCHLENKER TL STANGE KC WESTREICH L Acute confusional state: Don’t Lead poisoning in children: The See Frank SH Delirium and acute psychosis: mistake it for dementia. 92(8):141 ramifications and the road to pre- STEIN GE Mental states calling for clear di- PETERSON IM vention. 92(5):69 The new macrolide antibiotics: agnostic thinking and careful Autologous transfusion: A safe SCHOCKCOR WT Azithromycin and clarithromycin. management. 92(5):319 alternative for the 1990s. See Lange WR 92(1):269 WHIPPERMAN M SCOTT D STERNBACH GL See Peterson IM Are your patients satisfied? See Sadovnikoff N; Varon J Pruritus: What to do when the Strategies that may help you SUMRALL E itching won't stop. 92(7):34 avoid a formal complaint. (Com- See Love N (PN) PORAYKO MK mentary) 92(5):169 SWEET DE See Porayko MK Management of ascites in pa- SELF TH See Jewell ME WILCOX D tients with cirrhosis: What to do Correct use o¢ metered-dose See Peterson IM when diuretics fail. 92(8):155 inhalers and spacer devices. TAN JS WILLIAMS L POUND DC 92(3):95 See File TM Jr Ovarian cancer screening: The See Kumar S See also Rumbak MJ TENNER S search for cost-effective meth- SELIG MB Sideroblastic anemia: A diagno- ods. 92(8):63 RATH GD Acute myocardial infarction: An sis to consider in alcoholic pa- WILLIAMS RS Bladder cancer, 1992. 92(1):105 updated protocol for thrombolyt- tients. (CR) 92(7):147 Benefits and risks of oral con- RICHARDS JF ic therapy. 92(1):209 traceptive use. 92(7):155 See Lichtenhan JB SETNESS PA UMFRID RP WRIGHT TL RIDDLE MC See Farnes SW Nuclear myocardial perfusion Chronic hepatitis B and C: Combining insulin and sulfonyi- SHARIF K imaging in acute myocardial in- What is the status of drug thera- urea: A therapeutic option for See Mehra MR farction: Which technique is py? 92(4):75 type II diabetes. 92(2):89 SHOCKCOR T best? 92(7):109 RIFKIN A See Elnicki DM YANG RD Depression in physically ill pa- sim TC VALENZUELA JE Dysphagia: A practical approach tients: Don’t dismiss it as ‘un- Anaphylaxis: How to manage See Yang RD to diagnosis. 92(7):129 derstandable.’ 92(3):147 and prevent this medical emer- INSON N gency. 92(5):277 See Lange WR SKELTON NK ROBSON WLM Medical implications of obesi- See Leung AKC ty: Losing pounds, gaining years. ROGERS Ai 92(1):151 Medical therapy in Crohn’s dis- SKELTON WP Ili ease. 92(8):169 See Skelton NK ROLLHAUSER C SMITH CJ See Tenner S In Indian country. (MEM) RUDE RK 92(6):201 Magnesium deficiency and dia- SMITH CK betes mellitus: Causes and ef- See Frank SH fects. 92(5):217 SMITH EA RUMBAK MJ Cardiac rehabilitation, level 1. A diagnostic approach to ‘diffi- (PN) 92(7):179 cult’ asthma. 92(3):80 Cardiac rehabilitation, level 2. Metered-dose inhalers. (PN) (PN) 92(8):261 92(3):275 See also Self TH VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE

ebook img

Postgraduate Medicine 1992: Vol 92 Index PDF

9 Pages·1992·2.8 MB·English
by  
#periodicals #sim_microfilm #pub_postgraduate-medicine
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Postgraduate Medicine 1992: Vol 92 Index

INDEX TO POSTGRADUATE VOLUME 92 MEDICINE JULY-DECEMBER 1992 SUBJECTS ACCIDENT PREVENTION AIRWAY OBSTRUCTION BITES AND STINGS operative factors affecting out- e OSHA’S new regulations on e Anaphylaxis, management, e Animal bites, current manage- come. 92(5):265* bloodborne pathogens. (ED) preventive measures. 92(5):277* ment guidelines. 92(1):134* ¢ Coronary artery disease risk 92(1):17 e Asthma, diagnostic approach. e Anopheles mosquito, malaria, factors in persons with type Il di- ACNE 92(3):80* prophylaxis for world travelers. abetes, relationship to glucose ¢ Retinoid therapy, benefits and e Asthma, new approach to 92(3):161* metabolism. 92(2):105* risks, guidelines for treatment. management. 92(6):177* BLOOD e Hypertension in elderly, treat- 92(6):193 ¢ In aspiration pneumonia. 92(1): e Autologous transfusion, an- ment recommendations. 92(1): e Vulgaris, topical and systemic 168 swers to commonly asked ques- 237* therapies. 92(5):181* ALCOHOLISM tions. 92(3):253* ¢ Hypertension in post-myocar- ACQUIRED IMMUNODEFICIENCY ¢ Cause of sideroblastic anemia, BREAST DISEASES dial infarction patient, pharma- SYNDROME (AIDS) hematologic evaluation. (CR) ¢ Cancer, legal issues in man- cotherapy for long-term out- ¢ HIV infection in athletes, risks 92(7):147 agement. 92(5):137* come. 92(3):173* in sports setting, guidelines for ALLERGY ¢ Common breast lesions, evalu- * Hypertension, interrelation- sports physicians. 92(7):73* e Anaphylactic reaction, man- ation and management. 92(5):95* ships to exercise and antihyper- ¢ Rheumatic syndromes in HIV- agement of medical emergency, ¢ Mammographic imaging of tensive drug therapy. 92(6):139* infected patients. 92(4):99* preventive measures. 92(5):277* breast, overview of capabilities ¢ Implantable cardioverter-defib- © Seropositive but asymptomatic ¢ Role in asthma. 92(3):83* and limitations. 92(5):117* rillators for prevention of sudden patients, evaluation and manage- ANAPHYLAXIS ¢ Mammography. (PN) 92(5):353 cardiac death, current recom- ment by primary care physician. ¢ Management and prevention mendations. 92(1):301* 92(5):155* of medical emergency. 92(5):277* CANCER: See Neoplasms * Ischemic heart disease, preop- ADOLESCENT MEDICINE: See ANEMIA CARDIOVASCULAR D erative risk assessment. 92(5): Pediatrics ¢ Of chronic disease, clues to e Antiatherosclerotic effects of AGING differentiate from iron deficiency. calcium channel blockers for hy- ¢ Myocardial infarction, acute, e Age-related skin changes, 92(4):123* pertension. 92(2):265* assessing damage and predict- benefits and risks of retinoid ¢ Sideroblastic, alcohol-induced, © Atrial fibrillation, anticoagulant ing prognosis with nuclear myo- therapy, guidelines for treatment. hematologic evaluation. (CR) therapy, recommendations from cardial perfusion imaging. 92(7): 92(6):191* 92(7):147 recent studies. 92(3):119* ¢ Common thyroid disorders, ANTIBIOTICS: See Drugs, antibi- ¢ Beneficial cardiac effects of ¢ Myocardial infarction, acute, accurate diagnosis and rational otic hormone replacement therapy. updated protocol for thrombolyt- management. 92(3):225* ARTHRITIS: See Rheumatic dis- 92(4):146 ic therapy. 92(1):209* e Fever of unknown origin in el- eases ¢ Cardiac complications follow- ¢ Myocardial infarction, assess- derly, steps to diagnosis. 92(5): ASTHMA ing surgery, role of primary care ing long-term prognosis. 92(8): 197° e Avoiding triggers. (PN) 92(4): physician in prevention. 92(3): 107* ¢ Hypertension, treatment rec- 175 89* ¢ Myocardial infarction, using ommendations. 92(1):237* © Diagnostic approach. 92(3):80* ¢ Cardiac complications of sub- echocardiography in evaluation. e Postoperative acute confu- * Metered-dose inhalers. (PN) stance abuse. 92(3):205 92(7):97* sional state in elderly, role of pri- 92(3):274 ¢ Cardiac enzyme levels in con- ¢ Myocardial infarctior, various mary care physician in preven- ¢ Metered-dose inhalers and firming acute myocardial infarc- therapies to prevent reinfarction tion. 92(3):196 spacer devices. 92(3):95* tion. 92(7):85* 92(8):84* e Risk factor for acute confu- ¢ Occupational, mechanisms ¢ Cardiac imaging after acute e Post-myocardial infarction pa- sional state. 92(8):142 and causes, diagnosis, and treat- myocardial infarction to identify tient with hypertension, comple- ¢ Risk of bladder cancer in el- ment. 92(3):109* patients at continued risk. mentary use of beta blockers and derly men. 92(1):105 e Reevaluation of management 92(8):93* calcium channel blockers for ¢ Risk of tetanus, diagnosis and strategies, new approach in ¢ Cardiac irregularities from secoridary prevention. 92(3):173* treatment. 92(7):59* 1990s. 92(6):177* magnesium deficiency. 92(5):218 ¢ Postoperative myocardial in- ¢ Thrombolytic therapy for acute ¢ Wheezing and dyspnea result- ¢ Cardiac rehabilitation, level 1. farction, management. 92(5):2771 myocardial infarction in elderly. ing from vocal cord dysfunction, (PN) 92(7):179 ¢ Proarrhythmic complications 92(1):210 not asthma. (CR) 92(6):153 ¢ Cardiac rehabilitation, level 2. from quinidine. 92(4):133 AIDS: See Acquired immunodefi- (PN) 92(8):261 e Rehabilitation following heart ciency syndrome (AIDS) BEHAVIOR DISORDERS e Cardiovascular risk factors, attack. (PN) 92(7):179; (PN) 92(8): e Accompanying Tourette’s syn- psychophysiologic responses to 261 drome. 92(5):306 stress and clinical conse- e Rheumatic fever, resurgence in ¢ Acute confusional state, clini- quences. 92(5):237* United States, diagnosis and *Major clinical discussion cal presentation, evaluation, and ¢ Cerebral infarctions, diagnostic treatment. 92(3):133* CR, Case Report management. 92(8):141* studies and therapeutic regimens e Risk in obese patients. 92(1): ED, Editorial BIOPSY that help avoid stroke in middle- 155 MEM, Memories Worth Sharing e Renal, in evaluation of adults aged and older patients. 92(2): ¢ Sudden cardiac death during PH, Physician-at-Large with primary nephrotic syndrome. 221 exercise, identifying those at risk. PN, Patient Notes 92(2):213 * Coronary artery disease, peri- 92(2):195* continued VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED e Vascular complications of sub- relationship to glucose metab- ment for women with acute uri- DRUGS, CALCIUM CHANNEL stance abuse. 92(3):207 olism. 92(2):105* nary tract infection. 92(6):159* BLOCKER CATHETERIZATION e Type Il (non-insulin-depen- ¢ For Crohn’s disease, results of ¢ Antiatherosclerotic effects. © Indwelling urinary catheters, dent), physician’s role in non- drug trials. 92(8):173 92(2):265* management recommendations. pharmacologic treatment and pa- e For infected animal bites. © Following myocardial infarction 92(1):127° tient education. 92(6):129* 92(1):136 to prevent reinfarction. 92(8):87 CHOLESTEROL DIAGNOSTIC TECHNIQUES e Macrolide, newer agents— ¢ For post-myocardial infarction e Effect of insulin on low-density ¢ Barium enema, role in detect- azithromycin and clarithromycin. patients with hypertension. 92(3): and high-density lipoproteins. ing colorectal disease, radiolo- 92(1):269* 175 92(2):106 gist’s perspective. 92(3):245* © Prophylaxis in cases of animal DRUGS, CONTRACEPTIVE COLD © Cardiac enzyme levels in con- bites. 92(1):136 ¢ Oral, benefits and risks. 92(7): © Hypothermia, diagnosis, treat- firming acute myocardial infarc- e Sulfasalazine in management 155” ment, and prognosis. 92(8):47* tion. 92(7):85* of Crohn’s disease, results of e Oral, role in management of COLONIC DISEASES: See Gas- e Cardiac imaging after acute drug trials. 92(8):168 endometriosis. 92(1):292 trointestinal diseases myocardial infarction to identify DRUGS, ANTICOAGULANT DRUGS, CORTICOSTEROID CONNECTIVE TISSUE DISEASE patients at continued risk. 92(8): e For atrial fibrillation, recom- e For asthma. 92(6):186 © Cause of fever in elderly. 92(5): 93* mendations based on results of ¢ In treating Crohn’s disease, re- 198 © Cost-effective screening for recent studies. 92(3):119* sults of drug trials. 92(8):170 CONTRAST MEDIA ovarian cancer. 92(8):63* ¢ To prevent reinfarction after DRUGS, DIURETIC e Radiocontrast-induced ne- ¢ Echocardiography, capabilities myocardial infarction. 92(8):88 ¢ For managing ascites in pa- phropathy, risk factors and pre- in evaluation cf myocardial in- DRUGS, ANTIDEPRESSANT tients with cirrhosis. 92(8):155 ventive measures. 92(8):215* farction. 92(7):97* e Use in physically ill patient DRUGS, HORMONE ¢ Objective testing for asthma. treated for depression. 92(3):149 ¢ Postmenopausal replacement DEATH/DYING 92(3):112 DRUGS, ANTIHISTAMINES therapy, risks, screening recom- ¢ Sudden, during exercise, his- e Preoperative, patients with ¢ Oral, first- and second-genera- mendations. 92(4):145* tory and causes, identifying ischemic heart disease. 92(5):257 tion, for pruritus. 92(7):43 DRUGS, IMMUNOSUPPRESSIVE those at risk. 92(2):195* e Serologic diagnosis of viral DRUGS, ANTIHYPERTENSIVE ¢ For Crohn's disease, results of DELIVERY OF HEALTHCARE hepatitis. 92(4):55* e Maximizing benefits of exer- drug trials. 92(8):170 ¢ Comparison of 11 healthcare DIARRHEA cise in patients receiving antihy- DRUGS, NONSTEROIDAL ANTI- plans. (ED) 92(2):21 e “Halloween,” side effect of sor- pertensive drug therapy. 92(6): INFLAMMATORY (NSAID) ¢ Comparisons of Bush and bitol-containing candy. (CR) 139° ¢ Cromolyn sodium for asthma. Clinton healthcare plans. (ED) 92(5):63 DRUGS, ANTIMALARIAL 92(6):185 92(5):15 e In Crohn’s disease, therapeutic ¢ Traits, benefits, and side ef- DRUGS, RETINOID © Letter to President-elect Clin- options. 92(8):168 fects. 92(3):165 e For acne and age-related skin ton. (ED) 92(8):21 DIET: See Nutrition DRUGS, ANTIMICROBIAL changes, benefits and risks, ¢ National health insurance, DRUG ABUSE e In management of community- guidelines for treatment. 92(6): Ralph Nader’s viewpoint. (ED) ¢ Medical complications, over- acquired pneumonia. 92(8):207 191 92(6):15 view. 92(3):205* DRUGS, ANTIPSYCHOTIC DRUGS, SALICYLATE ¢ President Bush’s healthcare DRUG INTERACTIONS e For delirium and acute psy- e Aspirin therapy for atrial fibril- plan for the nation—and an ¢ Systemic, with oral contracep- chosis. 92(5):320, 326, 328 lation, recent study results. 92(3): overview of his health status. tives. 92(7):162 DI , AN TIVIRAL 120 (ED) 92(4):13 © With sulfonylureas. 92(2):74 ¢ Interferon, for treatment of DRUGS, SIDE EFFECTS DEPRESSION DRUG THERAPY chronic hepatitis B and C. 92(4): ¢ Antidepressant therapy, risk- ¢ In physically ill patients, diag- e Drug trials on treatment of 75* benefit ratio in treating de- nosis, use of antidepressants, Crohn’s disease. 92(8):168* DRUGS, BETA AGONIST pressed, physically ill patients. tips on safe treatment. 92(3):147* e For asthma, new approach for e Metered-dose inhalers and 92(3):153 DIABETES 1990s. 92(6):177* spacer devices in management ¢ From quinidine. 92(4):132 ¢ Exercise—benefits, risks, pre- ¢ Thrombolytic therapy for acute of asthma, teaching correct use, ¢ From retinoid therapy of acne. cautions. 92(1):183* myocardial infarction, updated patient problems and solutions. 92(6):195 © Foot care. (PN) 92(2):289 protocol. 92(1):209* 92(3):95* DRUGS, SULFONYLUREA * Health risk of obesity. 92(1): © Zidovudine therapy for asymp- DRUGS, BETA BLOCKER ¢ Combined with insulin to treat 154 tomatic HIV-infected patients, ¢ Following myocardial! infarction type II diabetes. 92(2):89* ¢ Magnesium deficiency, causes when to start. 92(5):161 to prevent reinfarction. 92(8):87* e For non-insulin-dependent and effects. 92(5):217* DRUGS, ANGIOTENSIN-CONVERT- ¢ For post-myocardial infarction (type II) diabetes, when and when ¢ Non-insulin-dependent (type ING ENZYME INHIBITOR patients with hypertension. not to use. 92(2):69* ll), combining insulin and sulfo- ¢ To prevent reinfarction after 92(3):175 DRUGS, THROMBOLYTIC nylurea. 92(2):89* myocardial infarction. 92(8):87 DRUGS, BRONCHODILATOR ¢ Protocol for use in acute myo- ¢ Non-insulin-dependent (type DRUGS, AN HMIC ¢ Betas agonists for asthma. cardial infarction. 92(1):209* ll), rational use of sulfonylureas. © Quinidine, safety and effective- 92(6):183 DYSPHAGIA 92(2):69° ness. 92(4):131* e Theophylline preparations for ¢ Pinpointing cause with radio- © Type Il, lipid metabolism and DRUGS, ANTIBIOTIC asthma. 92(6):185 graphic, endoscopic, and mano- e Agents and course of treat- metric studies. 92(7):129* continued on page 233 VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED ECHOCARDIOGRAPHY ¢ Role in treating post-polio syn- ¢ Testicular cancer, screening IMMUNOLOGIC DISEASES e In evaluation of myocardial in- drome. 92(1):253 and education, role of primary ¢ Effects of substance abuse. farction. 92(7):97* EYE DISORDERS care physician. 92(1):93* 92(3):212 ¢ Two-dimensional, to identify ¢ Ophthalmic manifestations of e Testicular self-examination. © Impaired cell-mediated immu- patients at continued risk after Graves’ disease. 92(8):117 PN) 92(1):335 nity, factor in listerial meningitis. acute myocardial infarction. GERIATRICS: See Aging (CR) 92(8):191 92(8):95 FEVER GOVERNMENT AGENCIES ¢ Rheumatic syndromes in HIV- ELDERLY: See Aging « Rheumatic, resurgence in Unit- e OSHA’S new regulations on infected patients. 92(4):99" ELECTROCARDIOGRAPHY ed States, diagnosis and treat- bloodborne pathogens. (ED) INFECTION e In assessing risk factors and ment. 92(3):133* 92(1):17 — of fever in elderly. 92(5): long-term prognosis after myo- e Unknown origin in elderly, ¢ OSHA's response to informa- 197° cardial infarction. 92(8):107* steps to = 92(5):197* tion requests. (ED) 92(7):15 © Cause of pruritus. 92(7):36 ELECTROPHYSIOLOGIC STUDY FOOT DISORDERS GYNECOLOGY: See Obstetrics/ ¢ Community-acquired pneumo- ¢ Implantable cardioverter-defib- e In diabetics. (PN) 92(2):289 Gynecology nia, diagnosis and treatment. rillators for prevention of sudden FOREIGN BODIES 92(8):197* cardiac death, current recom- ¢ In gastrointestinal tract, guide- HEART DISEASE: See Cardiovas- © Complication of long-term uri- mendations. 92(1):301* lines for removal. 92(5):46* cular diseases nary catheterization, treatment EMERGENCY MEDICINE HEMATOLOGIC DISEASES recommendations. 92(1):129 e Anaphylaxis, management, GASTROINTESTINAL DISEASES ¢ Immune thrombocytopenic ¢ Human immunodeficiency preventive measures. 92(5):277 e Ascites in patients with cirrho- purpura, acute and chronic, clini- virus, evaluation and manage- ¢ Carbon monoxide poisoning, sis, treatment options. 92(8):155* cal features, laboratory findings, ment of seropositive but asymp- diagnosis and treatment. 92(4): e Barium enema in detection of and treatment options. 92(6):112 tomatic patient. 92(5):155* 86* colorectal diseases, radiologist’s © lron deficiency and anemia of ¢ Human immunodeficiency ¢ Hypothermia, recognizing sub- perspective. 92(3):245* chronic disease, diagnostic clues virus, in athietes, risks in sports tle signs and symptoms, treat- * Colon cancer, dietary effects. for differentiation. 92(4):123* setting, guidelines for sports ment and prognosis. 92(8):47* (PN) 92(6):221 * Sideroblastic anemia, alcohol- physicians. 92(7):73* ¢ Poisoning and overdose, cur- © Colonic div2rticula, overview of induced, hematologic evaluation. ¢ Listerial meningitis, sources of rent options for gastrointestinal therapeutic approaches. 92(6): (CR) 92(7):147 infection, coexisting conditions, decontamination and appropriate 97* HEMORRHOIDS and — tonatemaaeaa agents. (CR) applications. 92(2):116* ¢ Colorectal polyps, differentiat- © Office evaluation and manage- 92(8):191 ENDOCRINE DISORDERS ing benign from malignant, ment. 92(2):141 ¢ Malaria, or ye for world ¢ Addisonian crisis following screening and treatment, follow- HEPATITIS travelers. 92(3):16 surgery, role of primary care up and prevention. 92(6):53* e B and C, chronic, current drug ° a vaaieas. of bone and physician in prevention. 92(3):194 * Complications of substance treatment. 92(4):75* joint. 92(4):99 ¢ Cause of pruritus, evaluation abuse. 92(3):211 ¢ Viral, preexposure and postex- ¢ Perirectal and perianal ab- and treatment. 92(7):34 * Crohn’s disease, therapeutic posure prophylaxis. 92(4):43* scesses, office evaluation and ¢ Diabetes: See Diabetes options available, results of drug e Viral, tests for serologic diag- management. 92(2):144 ¢ Graves’ disease, treatment op- trials. 92(8):168* nosis. 92(4):55* ¢ Respiratory tract in children, tions. 92(8):117* e Dysphagia, pinpointing cause HEREDITARY DISEASES what helps and what doesn’t? e Thyroid disorders in elderly, with radiographic, endoscopic, ¢ Tourette’s syndrome, recogni- 92(2):235* accurate diagnosis and rational and manometric studies. 92(7): tion and management, promising e Rheumatic fever, resurgence in management. 92(3):225* 129° new drug therapies. 92(5):299* United States, diagnosis and ENVIRONMENTAL ¢ Foreign bodies in Gl tract, HORMONES treatment. 92(3):133* e Lead poisoning in children, guidelines for removal. 92(5):46* e Estrogen and progestin, bene- ¢ Risk with animal bites, current ramifications, screening and pre- e Gas and diarrhea caused by fits and risks. 92(7):155 management guidelines including vention. 92(5):69* sorbitol ingestion. (CR) 92(5):63 e Estrogen replacement therapy, antibiotic prophylaxis. 92(1):134* EQUIPMENT ¢ Gastrointestinal decontamina- postmenopausal protection. ¢ Tetanus, threat to elderly, diag- ¢ Metered-dose inhalers and tion after poisoning or overdose, 92(4):145* nosis and treatment, prevention spacer devices in asthma man- current options. 92(2):116* HYPERTENSION: See Cardiovas- with immunization. 92(7):59* agement, teaching correct use. e Inflammatory bowel disease, cular diseases e Urinary tract, acute, in women, 92(3):95* outpatient management. 92(6): HYPOTHERMIA changing ideas on treatment. EXERCISE e Diagnosis, treatment, and 92(6):159* e For patients with diabetes GENETIC DISORDERS: See He- prognosis. 92(8):47* INSOMNIA —benefits, risks, precautions. reditary diseases ¢ Situational, "as for treat- 92(1):183* GENITAL DISEASES IMMUNIZATION ment. 92(2):1 ¢ Interrelationships among exer- e Acute urinary tract infection in ¢ Current recommendations on INSULIN cise, hypertension, and antihy- women, changing ideas on treat- viral hepatitis. 92(4):43 e Used with sulfonylurea to treat pertensive drug therapy. 92(6): ment. 92(6):159* ¢ Tetanus status review in cases type Il diabetes. 92(2):89* 139* ¢ Female, endometriosis, diag- of animal bites. 92(1):144 INSURANCE, HEALTH ¢ Role in controlling non-insulin- nostic clues, treatment options. ¢ To prevent tetanus. 92(7):67 ¢ Comparison of 11 healthcare dependent diabetes. 92(6):129 92(1):283* plans. (ED) 92(2):21 continued VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED e Ralph Nader's pian for national MAMMOGRAPHY e Caused by tetanus, particularly OTORHINOLARYNGOLOGIC DiIS- health insurance. (ED) 92(6):15 ¢ Overview of capabilities and in elderly, diagnosis and treat- EASES e Reform in United States, com- limitations. 92(5):117* ment. 92(7):59* e Snoring, causes, complica- parisons of Bush and Clinton e Patient information. (PN) 92(5) ¢ Complications of substance tions, evaluation and manage- healthcare proposals. (ED) 92(5) 353 abuse. 92(3):207 ment. 92(3):217°* 15 MEDICAL PRACTICE e In listerial meningitis, sources e¢ Vocal cord dysfunction mim- INTESTINAL DISEASES: See Gas- ¢ How OSHA responds to com- of infection, coexisting condi- icking bronchial asthma. (CR) trointestinal diseases plaints about physicians’ office tions, and therapeutic agents 92(6):153 IRON practice methods. (ED) 92(3):29 (CR) 92(8):191 OXYGEN © Deficiency, differentiating from e OSHA’S new regulations on * Post-polio syndrome, possible ¢ Therapy for carbon monoxide anemia of chronic disease. 92(4) bloodborne pathogens. (ED) causes, current treatment poisoning. 92(4):93 123° 92(1):17 92(1):249* e Patient satisfaction, strategies © Stroke: See Stroke PATIENT EDUCATION KIDNEY DISEASES for avoiding formal complaints © Tourette’s syndrome, recogni- © Avoiding asthma triggers. (PN) e Cause of pruritus. 92(7):34 92(5):169 tion and management, promising 92(4):175 e Nephropathy, radiocontrast- MENINGITIS new drug therapies. 92(5):299* ¢ Breast self-examination. 92(5) induced, risk factors and preven- e Listerial, sources of infection, NUTRITION 95 tive measures. 92(8):215* coexisting conditions, and thera- e Diet and colon cancer. (PN) ¢ Cardiac rehabilitation, level 1 ¢ Nephrotic syndrome in adults, peutic agents. (CR) 92(8):191 92(6):221 (PN) 92(7):179 diagnosis and management MENSTRUATION DISORDERS e Eating behavior in obesity. ¢ Cardiac rehabilitation, level 2. 92(2):209* e¢ Amenorrhea and chronic 92(1):154 (PN) 92(8):261 ¢ Renal insufficiency, role in re- anovulation, finding and address- © Hypervitaminosis A. 92(6):199 © Counseling asymptomatic HIV- fractory ascites in patients with ing underlying cause. 92(2):255°* e Iron deficiency, cause of pruri- positive patients. 92(5):159 cirrhosis. 92(8):155 MUSCULOSKELETAL DISORDERS tus. 92(7):36 ¢ Diet and colon cancer. (PN) ¢ Muscle rigidity and spasm re- © Low-fiber diet and diverticular 92(6):221 LABORATORY INVESTIGATION sulting from tetanus, evaluation disease. 92(6):97 e Foot care for diabetics. (PN) e Cardiac enzyme levels in con- and treatment. 92(7):59 * Magnesium deficiency and di- 92(2):289 firming acute myocardial infarc- ¢ Myositis in HIV-infected pa- abetes, causes and effects. 92(5): ¢ Informed consent in manage- tion. 92(7):85* tients. 92(4):104 217° ment of breast disease, legal is- e In diagnosis of Graves’ dis- © Post-polio syndrome, possible ¢ Nutritional concerns in inflam- sues. 92(5):144 ease. 92(8):120 causes, current treatment. 92(1): matory bowel disease. 92(6):71 © Mammography. (PN) 92(5):353 * Serologic diagnosis of viral 249" ¢ Sorbitol in sugar-free foods, e Metered-dose inhalers. (PN) hepatitis. 92(4):55* side effects of gas and diarrhea. 92(3):274 ¢ Serum creatinine level in diag- NEOPLASMS (CR) 92(5):63 ¢ Role of physician in teaching nosis of radiocontrast-induced © Bladder cancer, identification, ¢ Weight loss and nutritional and offering support to control nephropathy. 92(8):222 staging, and treatment. 92(1): counseling in control of non- non-insulin-dependent diabetes. e Tests for detecting pathogen 105° insulin-dependent diabetes. 92(6):129* causing community-acquired ¢ Breast cancer, legal issues in 92(6):130 e Teaching correct use of me- pneumonia. 92(8):203 management. 92(5):137* tered-dose inhalers and spacer ¢ Thyroid function tests in elder- ¢ Breast cancer, mammographic OBESITY devices for asthma management. ly. 92(3):225 features. 92(5):118 e Medical implications. 92(1): 92(3):95* LIVER DISEASES ¢ Breast lesions, evaluation and 151° e Testicular self-examination. © Cirrhosis accompanied by as- management. 92(5):95* OBSTETRICS/GYNECOLOGY (PN) 92(1):335 cites, treatment options. 92(8): ¢ Colorectal polyps, screening e Amenorrhea and chronic PEDIATRICS and treatment, follow-up and anovulation, finding and address- e Acne vulgaris, topical and sys- ¢ Hepatitis B and C, chronic, prevention. 92(6):53* ing underlying cause. 92(2):255* temic therapies. 92(5):181* current drug treatment. 92(4):75* e Lymphoma, cause of fever in e Endometriosis, diagnostic e “Halloween diarrhea,” side ef- ¢ Viral hepatitis, preexposure elderly. 92(5):200 clues, treatment options. 92(1): fect of sorbitol-containing candy. and postexposure prophylaxis. ¢ Malignant, risk in obese pa- (CR) 92(5):63 92(4):43° tients. 92(1):156 * Oral contraceptives, benefits ¢ Immune thrombocytopenic ¢ Viral hepatitis, tests for sero- © Ovarian cancer, cost-effective and risks. 92(7):155* purpura, acute and chronic, clini- logic diagnosis. 92(4):55* screening methods. 92(8):63* e Ovarian cancer, cost-effective cal features, laboratory findings, ¢ Prostate cancer, update on screening methods. 92(8):63* and treatment options. 92(6):112* MAGNESIUM recognition and management. ¢ Postmenopausal hormone re- e Lead poisoning in children, © Deficiency in diabetics, causes 92(1):67* placement therapy. 92(4):145* ramifications, screening and pre- and effects. 92(5):217* ¢ Testicular cancer, screening e Reproductive complications of vention. 92(5):69* MALPRACTICE and education, role of primary substance abuse, effect on preg- e Respiratory infections, what ¢ Legal issues surrounding care physicians. 92(1):93 nancy. 92(3):213 helps and what doesn’t? 92(2): breast cancer care, recommen- NEUROLOGIC MANIFESTATIONS OCCUPATIONAL DISEASES 235* dations for decreasing liability e Acute confusional state, clini- e Asthma, mechanisms and ¢ Tetanus immunization. 92(7):67 risks. 92(5):137* cal presentation, evaluation, and causes, diagnosis, and treat- PHARYNGEAL Di management. 92(8):141* ment. 92(3):109* ¢ Pharyngitis and incidence of rheumatic fever in United States, VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE diagnosis and treatment. 92(3): ¢ Delirium and acute psychosis, RESPIRATORY DISEASES ¢ Testicular self-examination. 133* diagnosis and management. e Aspiration pneumonia, three (PN) 92(1):335 PHYSICAL EXAMINATION 92(5):319* distinct syndromes, recognition SKIN DISEASES ¢ Focused, in asymptomatic ¢ Depression in physically ill pa- and management, possibility of e Acne and age-related skin adults. 92(2):171* tients, diagnosis, use of antide- prevention. 92(1):165* changes, benefits and risks of PHYSICIAN-PATIENT RELATIONS pressants, tips on safe treatment. ¢ Asthma, diagnostic approach. retinoid therapy and guidelines e Assessing patient satisfaction, 92(3):147* 92(3):80* for treatment. 92(6):191* strategies for avoiding formal ¢ Obsessive-compulsive disor- e Asthma, management with ¢ Acne vulgaris, topical and sys- complaints. 92(5):169 der in patients with Tourette’s metered-dose inhalers and spac- ternic therapies. 92(5):181* PHYSICIANS syndrome. 92(5):306 er devices, teaching proper tech- e Pruritus, cutaneous and sys- * Sports, risks of HIV transmis- e Situational insomnia, guide- nique. 92(3):95* temic causes, treatment. 92(7): sion from infected athletes. 92(7): lines for treatment. 92(2):157* e Asthma, reevaluation of man- 34* 74 e Stress, psychophysiologic re- agement strategies. 92(6):177* SLEEP DISORDERS PNEUMONIA sponses and clinical conse- ¢ Avoiding triggers of asthma. ¢ Situational insomnia, guide- ¢ Aspiration, recognition and quences. 92(5):237* (PN) 92(4):175 lines for treatment. 92(2):157* management, possibility of pre- PUBLIC HEALTH * Carbon monoxide poisoning, e Snoring, causes, complica- vention. 92(1):165* ¢ Lead poisoning in children, so- diagnosis and treatment. 92(4): tions, evaluation and manage- ¢ Community-acquired, diagno- cietal ramifications, screening ment. 92(3):217* sis and treatment. 92(8):197* and prevention. 92(5):69* ¢ Infections in children, what SPORTS MEDICINE POISONING e Resurgence of rheumatic fever helps and what doesn’t? 92(2): © HIV infection in athletes, risks ¢ Carbon monoxide, diagnosis in United States. 92(3):133* in sports setting, guidelines for and treatment. 92(4):86* PULMONARY DISEASES: See ¢ Metered-dose inhalers. (PN) sports physicians. 92(7):73* ¢ Current options for gastroin- Respiratory diseases 92(3):274 STRESS testinal decontamination and ap- ¢ Occupational asthma, mecha- e Effect on heart, mechanisms, propriate applications. 92(2):116* RABIES nisms and causes, diagnosis and measurement, and management. © Lead, in children, ramifications, e Animal bites, current manage- treatment. 92(3):109* 92(5):237* screening and prevention. 92(5): ment guidelines including poten- e Pneumonia, community-ac- STROKE tial for rabies. 92(1):140 quired, diagnosis and treatment. e Avoiding, diagnostic studies POLYPS RADIOGRAPHY 92(8):197* and therapeutic regimens in mid- ¢ Colorectal, differentiating be- ¢ Chest, indications for use in ¢ Postoperative complications, dle-aged and older patients. nign and malignant, screening evaluating patients for pneumo- role of primary care physician in 92(2):221 and treatment, follow-up and nia. 92(8):202 prevention. 92(3):192 SUBSTANCE ABUSE: See Drug prevention. 92(6):53* RADIOLOGIC DIAGNOSIS ¢ Pulmonary complications of abuse PREGNANCY: See Obstetrics/Gy- e Barium enema in detecting substance abuse. 92(3):208 SURGERY necology colorectal disease, radiologist’s ¢ Respiratory symptoms result- ¢ For diverticular complications. PREVENTIVE MEDICINE perspective. 92(3):245* ing from vocal cord dysfunction. 92(6):101 ¢ Focused physical examination ¢ Cardiac imaging after acute (CR) 92(6):153 e Liver transplantation for refrac- in asymptomatic adults. 92(2): myocardial infarction to identify RHEUMATIC DISEASES tory ascites in patients with cir- 171* patients at -continued risk. e In HIV-infected patients. rhosis. 92(8):163 * Foot care in diabetics. (PN) 92(8):93* 92(4):99* © Management of endometriosis. 92(2):289 ¢ Mammographic imaging of 92(1):291 e Measures to prevent malaria breast, overview of capabilities SAFETY: See Accident prevention ¢ Noncardiac, in patients with for world travelers. 92(3):162 and limitations. 92(5):117* SCREENING ischemic heart disease, preoper- e Physician efforts to prevent ¢ Mammography. (PN) 92(5): 353 e Asymptomatic men for pros- ative risk assessment. 92(5):237* lead poisoning in ;oung children. ¢ Nuclear myocardial perfusion tate cancer. 92(1):71 e Perioperative factors affecting 92(5):71 imaging in acute myocardial in- 2 Athletes for risk of sudden car- outcome for patients with coro- ¢ Pneumonia prophylaxis in HIV- farction. 92(7):109* diac death. 92(2):205 nary artery disease, management infected patients. 92(5):162 RECTAL DISEASES ¢ Breast self-examination. 92(5): of postoperative myocardial in- e Preventing tetanus with immu- ¢ Colorectal polyps, screening 95 farction. 92(5):265* nization, prophylaxis after injury. and treatment, follow-up and ¢ For bladder cancer. 92(1):109 ¢ Preventing postoperative med- 92(7):67 prevention. 92(6):53* ¢ For colorectal cancer. 92(6):58 ical complications, role of prima- e Preventive strategies for viral ¢ Common anorectal problems, ¢ For lead exposure in children, ry care physician. 92(3):189* hepatitis, recommendations for office management. 92(2):141* CDC standards. 92(5):69 ¢ Vascular shunts for refractory preexposure and postexposure e Foreign bodies in rectum, e For ovarian cancer, cost-effec- ascites. 92(8):163 prophylaxis. 92(4):43* guidelines for removal. 92(5):56 tive methods. 92(8):63* PROSTATIC DISEASES e Role of barium enema in de- e For testicular cancer, role of THERAPEUTICS e Cancer, update on recognition tection, radiologist’s perspective. primary care physician in educa- e Environmental manipulation in and management. 92(1):67* 92(3):245* tion. 92(1):94 managing patients with delirium PSYCHIATRIC/PSYCHCSOCIAL REHABILITATION * Mammographic imaging of and acute psychosis. 92(5):319, DISORDERS © Cardiac, level 1. (PN) 92(7):179 breast, overview of capabilities 327 ¢ Acute confusional state, clini- © Cardiac, level 2. (PN) 92(8):261 and limitations. 92(5):117* e Interferon, for treatment of cal presentation, evaluation, and RENAL DISEASES: See Kidney ¢ Mammography. (PN) 92(5):353 chronic hepatitis B and C. 92(4): management. 92(8):141* diseases 75* continued VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED ¢ Oxygen therapy for carbon TRAVEL MEDICINE diagnosis and management. * Hepatitis, tests for serologic monoxide poisoning. 92(4):93 ¢ Malaria, prophylaxis for world 92(2):209* diagnosis. 92(4):55* ° Paracentesis in management travelers. 92(3):161* e Prostate cancer, update on ¢ Human immunodeficiency of ascites refractory to treatment TUMORS: See Neoplasms recognition and management. virus infection in athletes, risks in with diuretics. 92(8):161 92(1):67* sports setting, guidelines for THYROID DISEASES URINARY TRACT DISORDERS ¢ Testicular cancer, screening sports physicians. 92(7):73* ¢ Graves’ disease, treatment op- e Acute infection in women, and education, role of primary e Poliovirus, possible causes tions. 92(8):117* changing thoughts on treatment. care physician. 92(1):93* and current treatment of post- ¢ In elderly, accurate diagnosis 92(6):159* polio syndrome. 92(1):249* and rational management. 92(3): UROLOGIC DISEASES VACCINATION: See Immunization ¢ Rabies, potential in animal © Bladder cancer, identification, VASCULAR DISEASES: See Car- bites, management steps. THYROID FUNCTION TESTS staging, and treatment. 92(1): diovascular diseases 92(1):140 © In elderly. 92(3):225 105* VIRAL DISEASES VITAMINS TRAUMA e Indwelling urinary catheters, ¢ Hepatitis B and C, chronic, © Hypervitaminosis A. 92(6):199 e Animal bites, current manage- management recommendations. current drug treatment. 92(4):75* ment guidelines. 92(1):134* 92(1):127* * Hepatitis, preexposure and WOUNDS/INJURIES: See Trauma ¢ Carbon monoxide poisoning, ¢ Nephrotic syndrome in adults, postexposure prophylaxis. 92(4): diagnosis and treatment. 92(4):86* 43° AUTHORS ADLER CH tients are vulnerable? (CR) BERNSTEIN JA lems in independent and institu- See Dodick D 92(8):191 Occupational asthma: ‘My job tionalied patients. 92(1):127 AMIN NM ASTON JW Jr is making me sick!’ 92(3):109 BREITENBACH RA Prophylaxis for malaria: Helping Post-polio syndrome: An BIALER PA ‘Halloween diarrhea’: An unex- world travelers come home emerging threat to polio sur- See Westreich L pected trick of sorb. >I-contain- healthy. 92(3):161 vivors. 92(1):249 BLAKE GH ing candy. (CR) 92(5):63 ANDERSON CR AYOUB EM Control of type I! diabetes: BUFFA SD Animal bites: Guidelines to cur- Resurgence of rheumatic fever Reaping the rewards of exercise See Khawaja IT rent management. 92(1):134 in the United States: The and weight loss. 92(6):129 BURKE K ANDERSON EG changing picture of a preventable BLAND KI In sickness and in health. Eating humble pie. (MEM) iliness. 92(3):133 Evaluation of common breast (MEM) 92(5):81 92(8):75 masses. 92(5):95 BUSSE w Not the burying kind. (MEM) BEAN LC BODE FR Asthma in the 1990s: A new ap- 92(1):265 Cardiac imaging after acute See Mehra MR proach to therapy. 92(6):177 The shot felt ’round the world. myocardial infarction: |dentifi- BODEN WE BUTT F (MEM) 92(3):239 cation of patients at continued The post-myocardial infarction See Tenner S Wings of mercy. (MEM) 92(7): risk. 92(8):93 patient with hypertension: BUTT JH 117 BELL DSH Long-term outcome. 92(3):173 Outpatient management of in- APGAR BS Exercise for patients with dia- BOHANNON NJV flammatory bowel disease: Endometriosis: Diagnostic clues betes: Benefits, risks, precau- Lipid metabolism in type I! dia- Let’s keep it as simple as possi- and new treatment options. tions. 92(1):183 betes. 92(2):105 ble. 92(6):69 92(1):283 INETT HJ BRANDSTETTER RD APPLEGATE WB How to keep your practice in See Khawaja IT CAROME MA The hypertensive patient: Not the pink. (PH) 92(3):49 BRECHTELSBAUER DA Nephrotic syndrome in adults: just a number. 92(1):237 BERLAND 6B Care with an indwelling urinary A diagnostic and management ASHINSKY D Fever of unknown origin in the catheter: Tips for avoiding prob- challenge. 92(2):209 Listerial meningitis: Which pa- elderly: A sequential approach to continued diagnosis. 92(5):197 VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED CARR BR ELFRINK RJ Dear President Clinton. (ED) KUMAR S See Marshburn PB Colonic diverticula: When com- 92(8):21 Serologic diagnosis of viral CARUSO DR plications require surgery and Follow the rules: But tell us if hepatitis. 92(4):55 Intervention in Graves’ disease: when they don’t. 92(6):97 the feds target you unfairly! (ED) KUMASAKA BH Choosing among imperfect but ELIOT RS 92(1):17 Acne vulgaris: Topical and sys- effective treatment options. Stress and the heart: Mecha- The good and the bad about 11 temic therapies. 92(5):181 92(8):117 nisms, measurement, and man- healthcare plans. (ED) 92(2):21 CLARK R agement. 92(5):237 Hats and beds: Ralph Nader LANGE WR Breast imaging: A practical look ELNICKI DM thinks ‘it’s already working.’ (ED) Medical complications of sub- at its capabilities and its limita- Preventing postoperative medi- 92(6):15 stance abuse. 92(3):205 tions. 92(5):117 cal complications: How primary OSHA breaks a rule. (ED) LEUNG AKC CLARKSTON WK care physicians can help. 92(7):15 The ABZzzzs of snoring. Gastrointestinal foreign bodies: 92(3):189 Who was the phi phantom accuser 92(3):217 When to remove them, when to of 15 doctors? (ED) 92(3):29 LICHTENHAN JB watch and wait. 92(5):46 FARNES SW Tetanus: A threat to elderly pa- COELHO-BORGES S Retinoid therapy for aging skin HARRIS CR tients. 92(7):59 See Rogers Al and acne. 92(6):191 Gastrointestinal decontamina- LOVE N CORAPI MJ FILE TM Jr tion: Which method is best? Breast cancer: Improving your Coronary artery disease in sur- Community-acquired pneumo- 92(2):116 acumen in diagnosis. 92(5):85 gical patients: Perioperative nia: The changing picture. HAVLICHEK DH Mammography. (PN) 92(5):353 management. 92(5):265 92(8):197 See Stein GE See also Bland KI; Clark R; De- Coronary artery disease in sur- FOGOROS RN HIMBER P war MA gical patients: Preoperative How useful are implantable The wrong side of the bed. (PH) LYNCH JJ evaluation. 92(5):251 cardioverter defibrillators? 92(6):37 See Mamby SA CORREN J 92(1):301 HOUSTON MC Vocal cord dysfunction mim- FRANCIS T Exercise and hypertension: McHALE MS icking bronchial asthma. (CR) Common thyroid disorders in Maximizing the benefits in pa- See Vogt HB 92(6):153 the elderly. 92(3):225 tients receiving drug therapy. MACKNIN ML FRANK SH 92(6):139 Respiratory infections in chil- DAVIDSON MB The focused physical examina- dren: What helps and what Rational use of sulfonylureas. tion: Should checkups be tailor- JEWELL ME doesn’t? 92(2):235 92(2):69 made? 92(2):171 Asymptomatic HIV infection: A McRAE MA DELLA RATTA RK FREEDMAN SN primary care disease. 92(5):155 See Galle PC See Corapi MJ The role of barium enema in JOHNSON RJ MAMBY SA DePAOLIS M detecting colorectal disease: HIV infection in athletes: What Echocardiography: Using its Aggravation by mail. (PH) A radiologist’s perspective. are the risks? Who can com- many capabilities to evaluate 92(2):41 92(3):245 pie? 92(7):73 myocardial infarction. 92(7):97 The Big Bird doctor kit. (PH) Sudden death during exercise: MARSHALL JB 92(7):23 GALLE PC A cruel turn of events. 92(2):195 Diet and colon cancer. (PN) Doctors and other shoppers. Amenorrhea and chronic 92(6):221 (PH) 92(5):35 anovulation: Finding and ad- KAHN JK Polyps in the colon: Answers to Presents of mind. (PH) 92(8):27 dressing the underlying cause. Anticoagulant therapy for atrial key questions. 92(6):53 Soap suds. (PH) 92(4):19 92(2):255 fibrillation: Recommendations MARSHBURN PB Testing, one... two... (PH GILLIN JC from major studies. 92(3):119 Hormone replacement therapy: 92(1):31 Relief from situational insom- KELLERMAN RD Protection against the conse- DEWAR MA nia: Pharmacologic and other See Lichtenhan JB quences of menopause. 92(4): Legal issues in managing options. 92(2):157 KELSO TM 145 breast disease. 92(5):137 GLECKMAN RA See Self TH MATTIONI TA DINDZANS VJ See Berland B KEMP ED Long-term prognosis after myo- Viral hepatitis: Preexposure and GOLBUS J Prostate cancer: Finding and cardial infarction: Who is at risk postexposure prophylaxis. Rheumatic disease and AIDS: managing it. 92(1):67 for sudden death? 92(8):107 92(4):43 An interesting but mysterious re- KHAWAJA IT MAZZAFERRI EL DODICK D lationship. 92(4):99 Aspiration pneumonia: A threat See Caruso DR Tourette’s syndrome: Current GONZALEZ P when deglutition is compro- MEHRA MR approaches to recognition and See Tenner S mised. 92(1):165 Radiocontrast-induced ne- management. 92(5):299 GRIFFIN GC KINGSTON R phropathy: Prevention is better Avoiding things that trigger See Harris CR than cure. 92(8):215 EDMEADS J asthma. (PN) 92(4):175 KIRCHNER JT MIEDEMA BW How to avert impending stroke. Bush & his healthcare Acute and chronic immune See Elfrink RJ 92(2):221 plan—healthy! Some media re- thrombocytopenic purpura: MOHLER ER Jr ELDER NC ports—not! (ED) 92(4):13 Disorders that differ in more than lron deficiency and anemia of Acute urinary tract infection in Bush vs Clinton on artichokes, duration. 92(6):112 chronic disease: Clues to differ- women: What kind of antibiotic tomatoes, and healthcare. (ED) entiating these conditions. therapy is optimal? 92(6):159 92(5):15 92(4):123 continued VOL. 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE INDEX TO VOLUME 92 CONTINUED MOORE J Jr RUZICH RS SMITH LK VARON J See Carome MA Cardiac enzymes: How to use Medical treatment after myo- Hypothermia: Saving patients MOORE P serial determinations to confirm cardial infarction: Results of from the big chill. 92(8):47 See Frank SH acute myocardial infarction. studies using various methods. See also Sadovnikoff N 92(7):85 92(8}:84 VOGT HB NEMEC L SOWERS JR Testicular cancer: Role of pri- See Clark R SADOVNIKOFF N Antiatherosclerotic effects of mary care physicians in screen- NEWMAN KB Carbon monoxide poisoning: calcium channel blockers. ing and education. 92(1):93 See Corren J An occult epidemic. 92(4):86 92(2):265 See also Varon J STAHL TJ WARTOFSKY L ODLAND PB SALERNO DM Office management of com- See Francis T See Kumasaka BH Quinidine: Is it a good drug or a mon anorectal problems. WASSERSUG JD bad drug? 92(4):131 92(2):141 Giving thank: s. (MEM) 92(2):135 PETERSEN RC SCHLENKER TL STANGE KC WESTREICH L Acute confusional state: Don’t Lead poisoning in children: The See Frank SH Delirium and acute psychosis: mistake it for dementia. 92(8):141 ramifications and the road to pre- STEIN GE Mental states calling for clear di- PETERSON IM vention. 92(5):69 The new macrolide antibiotics: agnostic thinking and careful Autologous transfusion: A safe SCHOCKCOR WT Azithromycin and clarithromycin. management. 92(5):319 alternative for the 1990s. See Lange WR 92(1):269 WHIPPERMAN M SCOTT D STERNBACH GL See Peterson IM Are your patients satisfied? See Sadovnikoff N; Varon J Pruritus: What to do when the Strategies that may help you SUMRALL E itching won't stop. 92(7):34 avoid a formal complaint. (Com- See Love N (PN) PORAYKO MK mentary) 92(5):169 SWEET DE See Porayko MK Management of ascites in pa- SELF TH See Jewell ME WILCOX D tients with cirrhosis: What to do Correct use o¢ metered-dose See Peterson IM when diuretics fail. 92(8):155 inhalers and spacer devices. TAN JS WILLIAMS L POUND DC 92(3):95 See File TM Jr Ovarian cancer screening: The See Kumar S See also Rumbak MJ TENNER S search for cost-effective meth- SELIG MB Sideroblastic anemia: A diagno- ods. 92(8):63 RATH GD Acute myocardial infarction: An sis to consider in alcoholic pa- WILLIAMS RS Bladder cancer, 1992. 92(1):105 updated protocol for thrombolyt- tients. (CR) 92(7):147 Benefits and risks of oral con- RICHARDS JF ic therapy. 92(1):209 traceptive use. 92(7):155 See Lichtenhan JB SETNESS PA UMFRID RP WRIGHT TL RIDDLE MC See Farnes SW Nuclear myocardial perfusion Chronic hepatitis B and C: Combining insulin and sulfonyi- SHARIF K imaging in acute myocardial in- What is the status of drug thera- urea: A therapeutic option for See Mehra MR farction: Which technique is py? 92(4):75 type II diabetes. 92(2):89 SHOCKCOR T best? 92(7):109 RIFKIN A See Elnicki DM YANG RD Depression in physically ill pa- sim TC VALENZUELA JE Dysphagia: A practical approach tients: Don’t dismiss it as ‘un- Anaphylaxis: How to manage See Yang RD to diagnosis. 92(7):129 derstandable.’ 92(3):147 and prevent this medical emer- INSON N gency. 92(5):277 See Lange WR SKELTON NK ROBSON WLM Medical implications of obesi- See Leung AKC ty: Losing pounds, gaining years. ROGERS Ai 92(1):151 Medical therapy in Crohn’s dis- SKELTON WP Ili ease. 92(8):169 See Skelton NK ROLLHAUSER C SMITH CJ See Tenner S In Indian country. (MEM) RUDE RK 92(6):201 Magnesium deficiency and dia- SMITH CK betes mellitus: Causes and ef- See Frank SH fects. 92(5):217 SMITH EA RUMBAK MJ Cardiac rehabilitation, level 1. A diagnostic approach to ‘diffi- (PN) 92(7):179 cult’ asthma. 92(3):80 Cardiac rehabilitation, level 2. Metered-dose inhalers. (PN) (PN) 92(8):261 92(3):275 See also Self TH VOL 92/NO 8/DECEMBER 1992/POSTGRADUATE MEDICINE

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users